284 related articles for article (PubMed ID: 21047923)
1. TNF-alpha antagonism with etanercept decreases glucose and increases the proportion of high molecular weight adiponectin in obese subjects with features of the metabolic syndrome.
Stanley TL; Zanni MV; Johnsen S; Rasheed S; Makimura H; Lee H; Khor VK; Ahima RS; Grinspoon SK
J Clin Endocrinol Metab; 2011 Jan; 96(1):E146-50. PubMed ID: 21047923
[TBL] [Abstract][Full Text] [Related]
2. Effects of TNF-alpha antagonism on E-selectin in obese subjects with metabolic dysregulation.
Zanni MV; Stanley TL; Makimura H; Chen CY; Grinspoon SK
Clin Endocrinol (Oxf); 2010 Jul; 73(1):48-54. PubMed ID: 19878508
[TBL] [Abstract][Full Text] [Related]
3. Effects of TNF-alpha neutralization on adipocytokines and skeletal muscle adiposity in the metabolic syndrome.
Lo J; Bernstein LE; Canavan B; Torriani M; Jackson MB; Ahima RS; Grinspoon SK
Am J Physiol Endocrinol Metab; 2007 Jul; 293(1):E102-9. PubMed ID: 17374698
[TBL] [Abstract][Full Text] [Related]
4. Effects of etanercept in patients with the metabolic syndrome.
Bernstein LE; Berry J; Kim S; Canavan B; Grinspoon SK
Arch Intern Med; 2006 Apr; 166(8):902-8. PubMed ID: 16636217
[TBL] [Abstract][Full Text] [Related]
5. Estrogen sulfotransferase is expressed in subcutaneous adipose tissue of obese humans in association with TNF-alpha and SOCS3.
Ahima RS; Stanley TL; Khor VK; Zanni MV; Grinspoon SK
J Clin Endocrinol Metab; 2011 Jul; 96(7):E1153-8. PubMed ID: 21543429
[TBL] [Abstract][Full Text] [Related]
6. Metabolic and vascular effects of tumor necrosis factor-alpha blockade with etanercept in obese patients with type 2 diabetes.
Dominguez H; Storgaard H; Rask-Madsen C; Steffen Hermann T; Ihlemann N; Baunbjerg Nielsen D; Spohr C; Kober L; Vaag A; Torp-Pedersen C
J Vasc Res; 2005; 42(6):517-25. PubMed ID: 16155368
[TBL] [Abstract][Full Text] [Related]
7. The role of multicomponent therapy in the metabolic syndrome, inflammation and cardiovascular risk in obese adolescents.
Masquio DC; de Piano A; Campos RM; Sanches PL; Carnier J; Corgosinho FC; Netto BD; Carvalho-Ferreira JP; Oyama LM; Nascimento CM; de Mello MT; Tufik S; Dâmaso AR
Br J Nutr; 2015 Jun; 113(12):1920-30. PubMed ID: 25907896
[TBL] [Abstract][Full Text] [Related]
8. Association of serum C1q/TNF-Related Protein-9 (CTRP9) concentration with visceral adiposity and metabolic syndrome in humans.
Hwang YC; Woo Oh S; Park SW; Park CY
Int J Obes (Lond); 2014 Sep; 38(9):1207-12. PubMed ID: 24357853
[TBL] [Abstract][Full Text] [Related]
9. The relationship between serum adiponectin, tumor necrosis factor-alpha, leptin levels and insulin sensitivity in childhood and adolescent obesity: adiponectin is a marker of metabolic syndrome.
Alikaşifoğlu A; Gönç N; Özön ZA; Sen Y; Kandemir N
J Clin Res Pediatr Endocrinol; 2009; 1(5):233-9. PubMed ID: 21274300
[TBL] [Abstract][Full Text] [Related]
10. Predictors of the early impairment of renal disease in human obesity.
Gilardini L; Zulian A; Girola A; Redaelli G; Conti A; Invitti C
Int J Obes (Lond); 2010 Feb; 34(2):287-94. PubMed ID: 19859076
[TBL] [Abstract][Full Text] [Related]
11. Relationship of adipokine to insulin sensitivity and glycemic regulation in obese women--the effect of body weight reduction by caloric restriction.
Golubović MV; Dimić D; Antić S; Radenković S; Djindjić B; Jovanović M
Vojnosanit Pregl; 2013 Mar; 70(3):284-91. PubMed ID: 23607240
[TBL] [Abstract][Full Text] [Related]
12. Lower dipeptidyl peptidase-4 following exercise training plus weight loss is related to increased insulin sensitivity in adults with metabolic syndrome.
Malin SK; Huang H; Mulya A; Kashyap SR; Kirwan JP
Peptides; 2013 Sep; 47():142-7. PubMed ID: 23872069
[TBL] [Abstract][Full Text] [Related]
13. The role of a soluble TNFalpha receptor fusion protein (etanercept) in corticosteroid refractory asthma: a double blind, randomised, placebo controlled trial.
Morjaria JB; Chauhan AJ; Babu KS; Polosa R; Davies DE; Holgate ST
Thorax; 2008 Jul; 63(7):584-91. PubMed ID: 18245148
[TBL] [Abstract][Full Text] [Related]
14. Cardiometabolic biomarkers in chronic plaque psoriasis before and after etanercept treatment.
Puig L; Strohal R; Fuiman J; Pedersen R; Szumski A; Koenig AS; Robertson D; Drexel H
J Dermatolog Treat; 2014 Dec; 25(6):470-81. PubMed ID: 24219012
[TBL] [Abstract][Full Text] [Related]
15. Long-term etanercept therapy favors weight gain and ameliorates cachexia in rheumatoid arthritis patients: roles of gut hormones and leptin.
Chen CY; Tsai CY; Lee PC; Lee SD
Curr Pharm Des; 2013; 19(10):1956-64. PubMed ID: 23305268
[TBL] [Abstract][Full Text] [Related]
16. Effect of Ramadan diurnal fasting on visceral adiposity and serum adipokines in overweight and obese individuals.
Faris MAE; Madkour MI; Obaideen AK; Dalah EZ; Hasan HA; Radwan H; Jahrami HA; Hamdy O; Mohammad MG
Diabetes Res Clin Pract; 2019 Jul; 153():166-175. PubMed ID: 31150725
[TBL] [Abstract][Full Text] [Related]
17. Etanercept attenuates the development of cerulein-induced acute pancreatitis in mice: a comparison with TNF-alpha genetic deletion.
Malleo G; Mazzon E; Genovese T; Di Paola R; Muià C; Centorrino T; Siriwardena AK; Cuzzocrea S
Shock; 2007 May; 27(5):542-51. PubMed ID: 17438460
[TBL] [Abstract][Full Text] [Related]
18. Dynamic strength training improves insulin sensitivity without altering plasma levels and gene expression of adipokines in subcutaneous adipose tissue in obese men.
Klimcakova E; Polak J; Moro C; Hejnova J; Majercik M; Viguerie N; Berlan M; Langin D; Stich V
J Clin Endocrinol Metab; 2006 Dec; 91(12):5107-12. PubMed ID: 16968804
[TBL] [Abstract][Full Text] [Related]
19. Effect of lifestyle modification on adipokine levels in obese subjects with insulin resistance.
Monzillo LU; Hamdy O; Horton ES; Ledbury S; Mullooly C; Jarema C; Porter S; Ovalle K; Moussa A; Mantzoros CS
Obes Res; 2003 Sep; 11(9):1048-54. PubMed ID: 12972674
[TBL] [Abstract][Full Text] [Related]
20. In vitro hyperresponsiveness to tumor necrosis factor-alpha contributes to adipokine dysregulation in omental adipocytes of obese subjects.
Maury E; Noël L; Detry R; Brichard SM
J Clin Endocrinol Metab; 2009 Apr; 94(4):1393-400. PubMed ID: 19174496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
